baber/WOPTO huggingface dataset:
Patent EA-018398-B1 (EA)
Title: Method and apparatus producing three-dimentional image of an object
Inventor: ZAJTSEVA ELENA GEORGIEVNA
IPC: G02B27/22
Filed: 2010-10-28
Abstract: The invention relates to the field of recording and reproducing visual information. It serves to improve the quality of a three-dimensional image of the object, including the object that is removed at the distance from the place of shooting. To obtain a three-dimensional image 1 of the object 2 a camera 3 with a lens 4, a die 5 for converting optical radiation into an electrical signal, a processing and communication channel 6 for converting an electrical signal into a video-signal and its transmitting to the display 7 or several displays 7 and 8 and even a plurality of such displays (not shown) are used. There is also a node 9 to form an overall picture of the images using the displays 7, 8, a lens 10 and a plurality of flat mirrors 11 with the control system 12 to control the provisions of these mirrors. From the surface of the display 7 a set of flat images of the object 2 obtained in different angles is formed. If several displays 7 and 8 or a plurality of such displays are used, images generated by a node 9 contribute to the creation of the picture. The set of flat images of the object 2 in different angles formed by the lens 10 and a plurality of flat mirrors 11 forms the three-dimensional image 1.
Patent EA-021847-B1 (EA)
Title: Pharmaceutical composition with antimicrobial activity for parenteral use, process for preparing same
Inventor: GAIDUL KONSTANTIN VALENTINOVICH
IPC: B82Y5/00
Filed: 2011-05-11
Abstract: The invention relates to pharmacology, medicine and to the pharmaceutical industry, in particular to a process for preparing original composite antimicrobial preparations for parenteral use, said preparations having increased therapeutic effectiveness in the treatment of severe forms of infectious inflammatory diseases. The proposed pharmaceutical composition comprises an antibiotic - glycopeptide and highly dispersed nano-structured silicon dioxide as the active substance. The claimed process for preparing the pharmaceutical composition consists in mixing the antibiotic - glycopeptide substance with the highly dispersed nano-structured silicon dioxide, characterized in that the mixture of the above-mentioned substances in ratios of 10:1 to 70:1 by weight, respectively, is subjected to mechanical processing by means of impact-abrading actions to increase the finely dispersed fraction weight portion. The mixture produced is used for preparing injection solutions.
Patent EA-021178-B1 (EA)
Title: Phytases, nucleic acids encoding them and methods for making and using them
Inventor: WEINER DAVID P
IPC: C07H21/04
Filed: 2010-05-20
Abstract: The invention relates to phytases, polynucleotides encoding them, uses of the polynucleotides and polypeptides of the invention, as well as the production and isolation of such polynucleotides and polypeptides. In particular, the invention provides polypeptides having phytase activity under high temperature conditions, and phytases that retain activity after exposure to high temperatures. The invention further provides phytases which have increased gastric lability. The phytases of the invention can be used in foodstuffs to improve the feeding value of phytate rich ingredients. The phytases of the invention can be formulated as foods or feeds or supplements for either to, e.g., aid in the digestion of phytate.
Patent EA-019829-B1 (EA)
Title: Mobile communication system, base station apparatus, and mobile station apparatus
Inventor: AIBA TATSUSHI
IPC: H04W72/14
Filed: 2008-06-06
Abstract: A mobile communication system in which a mobile station apparatus transmits, to a base station apparatus, uplink data using a physical uplink shared channel assigned by an uplink data transmission permission signal, wherein the base station apparatus transmits, to the mobile station apparatus, a radio resource control signal including information for transmitting reception quality information and transmits, to the mobile station apparatus, the uplink data transmission permission signal including a transmission instruction of reception quality information, and wherein the mobile station apparatus transmits to the base station apparatus the first quality reception information according to the instruction of transmission the quality reception information included in the radio resource control signal; transmits to the base station apparatus the second quality reception information using the physical uplink shared channel in case, when the transmission instruction of reception quality information is included in the uplink data transmission permission signal and transmits to the base station apparatus the second quality reception information using the physical uplink shared channel in case when the first quality reception information and the second quality reception information are carried out simultaneously.
Patent EA-021061-B1 (EA)
Title: Process for the production of artemisinin intermediates
Inventor: KRAFT VOLKER
IPC: C07D493/18
Filed: 2010-09-10
Abstract: This application relates to a process for the production of (2R)-dihydroartemisinic acid or (2R)-dihydroartemisinic acid esters from artemisinic acid or artemisinic acid esters, respectively, by diimine hydrogenation of the exocyclic CC-double bond, and use of said process in the production of the antimalarial drug artemisinin.
Patent EA-036522-B1 (EA)
Title: Pharmaceutical composition suitable for lyophilization comprising a plurality of therapeutic particles
Inventor: TROIANO GREG
IPC: A61K47/30
Filed: 2010-12-10
Abstract: The invention relates to pharmaceutical compositions suitable for lyophilization comprising a plurality of therapeutic nanoparticles comprising copolymer is poly(lactic) acid-b/ocfc-poly(ethylene)glycol copolymer or poly(lactic)-co-poly(glycolic) acid-b/ocfc-poly(ethylene)glycol copolymer; and an active agent, which, upon reconstitution of a lyophilized pharmaceutical composition in less than or 100 mL of distilled water, comprise less than 6000 microparticles/mL having a size greater than or equal to 10 microns.
Patent EA-021871-B1 (EA)
Title: Medication for treatment of locomotor system disorders based on refined naphthalan mixed with zeolite
Inventor: MUSAEV ALISHIR VEIS OGLY
IPC: A61K35/644
Filed: 2012-05-10
Abstract: The invention relates to preparing a medication for treatment of inflammatory diseases of the locomotor system based on refined petroleum (naphthalan) and zeolite (clinoptilolite). Medications based on both naphthalan and zeolite (each separately) are known and have been used for a long time as medications for treatment of the locomotor system diseases. The claimed medication contains: zeolite - 18-25; paraffin+wax 1:1 - 16-20; sea salt - 3-5; Ag-zeolite - 1-3; refined naphthalan - the remainder. The essence of the claimed invention consists in that new ingredients are included in claimed amounts in the therapeutic compositions for the local treatment of inflammatory diseases of both joints and muscles and epidermis and their quantitative ratio provides activation of metabolic processes in the skin, normalizes the blood supply, eliminates congestion in inflammation zones, accelerates penetration of active medicinal substances into affected regions without inducing allergic reactions.
Patent EA-023509-B1 (EA)
Title: Method of treatment of maligant tumors
Inventor: PLETNEV SERGEY VLADIMIROVICH
IPC: A61N7/00
Filed: 2012-12-20
Abstract: The invention relates to oncology. The object of this invention is to provide reliable malignant tumor treatment methods, to reduce toxicity of the method and to enhance the role of immunity during the rehabilitation period. The above objects are to be achieved as follows. A method for combined treatment of malignant tumors comprises administering a sensitizing agent and exposing a malignant tumor to wave irradiation, wherein ultrasonic radiation is used as a wave irradiation.
Patent EA-027584-B1 (EA)
Title: Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
Inventor: HODOUS BRIAN L
IPC: C07D495/04
Filed: 2012-06-10
Abstract: The present invention provides novel pyrimidine compounds according to Formula (I)their use for the treatment of hyperproliferative diseases including, but not limited to, cancer, lupus, allergic disorders, Sjogren's disease and rheumatoid arthritis. In preferred embodiments, the present invention describes irreversible kinase inhibitors including, but not limited to, inhibitors of Bruton's tyrosine kinase.
Patent EA-024607-B1 (EA)
Title: Acetic acid production process
Inventor: SALISBURY BRIAN A
IPC: G01N21/65
Filed: 2011-10-18
Abstract: Disclosed is a method for controlling an acetic acid production process. The method comprises: (i) reacting methanol and carbon monoxide in the presence of a rhodium carbonylation catalyst in the initial concentration, a catalyst stabilizer in the initial concentration, methyl iodide, water in the initial concentration, and methyl acetate in the initial concentration to produce a reactor mixture which comprises the rhodium catalyst, the catalyst stabilizer, methanol, carbon monoxide, carbon dioxide, methyl iodide, methyl acetate, water, and acetic acid in the initial concentration; this reaction step further comprising the step of providing the presence of hydrogen where is fed or generated, wherein hydrogen enhances the rhodium carbonylation catalyst efficiency; (ii) measuring the initial concentration of carbon monoxide in the reactor mixture by Raman spectroscopic analysis; and (iii) adjusting the carbon monoxide concentration in the reactor mixture in response to the measured concentration, such that the regulated concentration of carbon monoxide was proper to achieve the regulated concentration of acetic acid in the reactor mixture. The method of the present invention provides a direct measurement of the carbon monoxide concentration in the reactor liquid mixture which improves the process control of the methanol carbonylation.
Patent EA-027020-B1 (EA)
Title: Fastening member and fastening segment of a wearing article
Inventor: SAKAGUCHI SATORU
IPC: A61F13/56
Filed: 2012-09-14
Abstract: Provided are a fastening member and a fastening segment for which an unpleasant texture and an incongruous appearance are significantly reduced, and that bring about an integrated feeling with the main body of a disposable article for wearing. A fastening segment 100 has a hook fastener 110 and a base sheet 120. A hook height H1 of a hook 111 is set to 45-150 μm, and a thickness T2 of a hook sheet is set to 45-75 μm. When in an L*a*b* color coordinate system, a color difference of L* is ΔL*, a color difference of a* is Δa*, and a color difference of b* is Δb*, a color difference ΔE between the hook fastener 110 and the base sheet 120 calculated using the ΔL*, Δa* and Δb*, is less than 5.5.
Patent EA-029942-B1 (EA)
Title: Stable pharmaceutical composition based on conjugates of biologically active proteins with polyethylene glycol containing an azo group
Inventor: SHEREMETIEV SERGEY VIKTOROVICH
IPC: C07K19/00
Filed: 2014-06-16
Abstract: The invention is related to the field of medicine and pharmaceutical industry and provides a pharmaceutical composition in a liquid or liophilized dosage form that contains pegylated protein in accordance with formula (I), wherein polyethylene glycol fragments are covalently connected to a protein molecule by means of azo groups:where Prot is a biologically active protein; A is an amino acid fragment of histidine; B is an amino acid fragment of tyrosine; n is an integer in an interval of 10 to 1200; m is an integer in an interval of 0 to 10; k is an integer in an interval of 0 to 10, wherein m≠k if m or k are equal to 0, in the form of a conjugate or a mixture of conjugates with different values of n, m and k, and pharmaceutically acceptable excipients selected from cosolvents, salts, acids, bases, antioxidants, preserving agents, amino acids, proteins, carbohydrates, polymers, detergents and complexons. The technical result is broadening the range of medicinal products.
Patent EA-031194-B1 (EA)
Title: Electronic game device
Inventor: WOELS MARTIN
IPC: G07F17/32
Filed: 2012-07-19
Abstract: The present invention relates to a game device, more particularly in the form of a coin-operable or token-operable gaming machine and/or gambling device with multiple separate display units for presenting information, more particularly game contents and/or game information, wherein at least one of the display units is furnished with a touch panel for inputting control commands by touching. According to the present invention, the touch panel is formed continuously over at least one part of each of at least two different display units. By extending the touch panel across the boundary region or intermediate space between two display units, it is possible to achieve a continuously closed off front of the device, despite the use of multiple display units, whereby the structure of the corresponding device wall is simplified and the security against intrusion into the housing at gaps is increased.
Patent EA-029470-B1 (EA)
Title: Method of eliciting protective immunity against norovirus
Inventor: RICHARDSON CHARLES
IPC: A61K39/125
Filed: 2012-07-11
Abstract: The present invention relates to a method of eliciting protective immunity against Norovirus in a. human comprising administering parenterally to the human no more than a single dose of a vaccine composition, said single dose comprising genogroup I and/or genogroup II Norovirus virus-like particles (VLPs), wherein said genogroup I and/or genogroup II Norovirus VLPs comprise a capsid protein derived from a corresponding genogroup viral strain, wherein said dose of the vaccine comprises not more than 150 μg of genogroup I and/or genogroup II Norovirus VLPs.
Patent EA-030550-B1 (EA)
Title: Tamper evident closure
Inventor: GIOVANNINI MARCO
IPC: B65D55/02
Filed: 2014-02-10
Abstract: The invention relates to a tamper evident closure (1) for closing a mouth (11) of a container (10). The closure (1) has an inner part (20), an outer part (30) movable relative to the inner part (20) from a first position, corresponding to the position prior to first opening, to a second position, first reversible attachment means (40), capable of attaching the inner part (20) to the container (10) and second irreversible attachment means (50) capable of locking longitudinally said the outer part (30) relative to the inner part (20) in the second position. The second attachment means (50) comprise a deformable annular member (51) housed in the closure (1) and cooperating with the inner part (20) and the outer part (30) to lock the outer part (30) relative to the inner part (20) in the second position. Furthermore, upon first opening, the annular member (51) remains longitudinally stationary with respect to the inner part (20) and the container (10) and the outer part (30) can move relative to the annular member (51) from the first position to the second position.
Patent EA-032325-B1 (EA)
Title: Method for controlling lighting of an operating room with a portable pointer device
Inventor: LUOSTARINEN MARKKU
IPC: H05B37/02
Filed: 2014-01-28
Abstract: According to one exemplary embodiment, the invention relates to a method (100) for controlling lighting, the method using a portable pointer device for the focusing of lighting. By means of this device, its position for establishing position data is determined (130), and the position data are transmitted (150) to a control unit intended for controlling a lighthead, which unit controls the lighthead in such a way that the lighthead produces lighting for an object from a direction determined by the position data and location data. The location data have been established by determining a location of the pointer device in relation to the lighthead.
Patent EA-031146-B1 (EA)
Title: Rolling rod as an inner tool in the production of seamless metal hollow bodies and method for producing metal hollow bodies
Inventor: SCHAEFER NILS
IPC: B21B25/00
Filed: 2015-01-05
Abstract: The present invention relates to a rolling rod as an inner tool in the production of seamless hollow bodies, in particular in the elongation of metal hollow blocks into seamless pipes by means of a multi-stand rolling mill, having a surface having a nitrided layer. In order to achieve an increase in the service life of the rolling rod, the rolling rod according to the invention is made of a steel resistant to high temperatures having a chromium equivalent Crof more than 6.5, calculated according to Cr.=% Cr+% Mo+1,5×% Si+0,5×% Nb+2×% Ti (1), measured 0.5 mm below the surface of the rolling rod, having a yield strength of at least 450 MPa at 500°C, and having a tensile strength of at least 600 MPa at 500°C, and the nitrided layer has a depth of more than 0.15 mm from the surface and a nitriding hardness of more than 950 HV 0.5. The present invention further relates to a method for producing a seamlessly hot-rolled metal hollow body, in particular a steel pipe, wherein a previously produced hollow block is subjected to an elongation process in a multi-stand rolling mill over a rolling rod inserted into the hollow block, which rolling rod is described above, and the rolling rod is provided with a liquid lubricant before the rolling use, i.e., before the start of the insertion into the hollow block, which liquid lubricant is subsequently dried, wherein the rolling rod is inserted with a play of at least 10 mm with respect to the inside diameter of the hollow block and the hollow block has an average temperature of at least 1000°C immediately before the start of the insertion of the rod and the rod velocity Vduring the rolling in a rod rolling mill satisfies the following conditions at most: V=0.9×rod length/rolling time of last stand (3), V=0.9×V(4), wherein Vis the minimum velocity of the pipe material during the rolling in the rod rolling mill.
Patent EA-028921-B1 (EA)
Title: Phenoxyethyls
Inventor: FISHER MATTHEW JOSEPH
IPC: C07D221/20
Filed: 2014-12-11
Abstract: The present invention provides a compound of the Formula Iwherein X, R, R, R, R, R, R, R, R, Rand Rare as defined herein, or a pharmaceutically acceptable salt thereof.
Patent EA-033889-B1 (EA)
Title: Combination comprising sv2a ligand and positive allosteric modulator of metabotropic glutamatergic receptor subtype 2
Inventor: KLEIN BRIAN D
IPC: A61P25/08
Filed: 2015-01-20
Abstract: The present invention relates to a combination for the treatment or prevention of epilepsy and related disorders, neuropathic pain, migraine or resistant headache and bipolar and related disorders, comprising (a) a synaptic vesicle protein 2A ("SV2A") ligand selected for the group consisting of levetiracetam, brivaracetam and seletracetam; and (b) a positive allosteric modulator of metabotropic glutamatergic receptor subtype 2 selected from 1) a compound of formula (I) selected fromandor a pharmaceutically acceptable salt or a solvate thereof; and 2) a compound of formula (I-A)or a stereoisomeric form thereof; or a pharmaceutically acceptable salt or a solvate thereof. The invention provides an effective treatment with a lower effective dose and a more favourable side effect profile.
Patent EA-033984-B1 (EA)
Title: Multiple singling device
Inventor: GEBBEKEN MARTIN
IPC: A01C7/04
Filed: 2016-04-15
Abstract: The invention relates to a multiple singling device (2) which is mounted on a row unit (20) of an agricultural single-seed drilling machine (1) and has a split housing (13, 14) with a multifunctional center piece (12).
Patent EA-038329-B1 (EA)
Title: Chimeric polypeptide assembly and methods of making and using the same
Inventor: SCHELLENBERGER VOLKER
IPC: A61K38/24
Filed: 2016-08-26
Abstract: The invention relates to bispecific chimeric polypeptide assembly compositions comprising bulking moieties linked to binding domains by cleavable release segments that, when cleaved are capable of concurrently binding effector T cells with targeted tumor or cancer cells and effecting cytolysis of the tumor cells or cancer cells. The invention also provides compositions and methods of making and using the cleavable chimeric polypeptide assembly compositions.
Patent EA-034227-B1 (EA)
Title: Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
Inventor: WURTZ NICHOLAS R
IPC: A61P9/10
Filed: 2016-12-08
Abstract: The disclosure relates to compounds of formula I, which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also relates to compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
Patent EA-039441-B1 (EA)
Title: Pharmaceutical composition for topical application for treating infectious inflammatory diseases, method for producing and using same
Inventor: SYROV KIRILL KONSTANTINOVICH
Filed: 2016-11-24
Abstract: The invention relates to the field of medicine and the pharmaceutical chemical industry. Proposed are a pharmaceutical composition for treating infectious inflammatory diseases in the form of a solution for topical application, containing, as active ingredient, a combination of gramicidin S dihydrochloride, oxybuprocaine hydrochloride and cetylpyridinium chloride and, as excipients, ethanol 96%, sucralose, glycerol, citric acid monohydrate, sodium citrate, polysorbate, methylparaben, propylparaben, natural mint flavouring and purified water, and a method for producing and using the same.
Patent EA-038487-B1 (EA)
Title: Thiazole derivatives, pharmaceutical composition comprising same and uses thereof
Inventor: DAVIES DAVID THOMAS
Filed: 2018-07-20
Abstract: The invention relates to compounds which are thiazole of Formula (I), or a pharmaceutically acceptable salt thereof. Furthermore, the invention relates to a pharmaceutical composition comprising said compounds, as well as the uses of the compounds and a composition for the treatment or prevention of bacterial infection and for the removal or reduction of antibiotic resistance in Gram-negative bacteria.
Patent ES-2192904-B1 (ES)
Title: Nuevo material ceramico y su aplicacion de productos ceramicos terminados.
Inventor: LIMO CASALS JUAN JOSE
IPC: C03C6/08
Filed: 2000-07-05
Granted: 2005-02-16
Abstract: Nuevo material cerámico y su aplicación en la fabricación de productos cerámicos terminados. El material cerámico es una mezcla de 65-93 % (p/p) de vidrio granulado y 7-35 % (p/p) de yeso. Dicho material tiene su principal aplicación en la obtención de piezas cerámicas de diferentes formas y volúmenes, especialmente piezas decorativas, además de las clásicas baldosas cerámicas para construcción.
Patent ES-2182661-B1 (ES)
Title: Mecanismo de cierre de anillas para carpeteria.
Inventor: FURIO GARCERA AMPARO
IPC: B42F13/26
Filed: 2000-10-24
Granted: 2004-04-01
Abstract: Mecanismo de cierre de anillas para carpetería. Se realiza en dos piezas, una base (2) y unos elementos de cierre (8) realizados en inyección de material plástico. La base (2) tiene unos rebajes laterales de sustentación de los elementos de cierre (8) y éstos tienen a su vez medios de trabado entre sí, así como las correspondientes semianillas. De aplicación industrial en la fabricación de cierres de anillas para carpetas.
Patent ES-2190748-B1 (ES)
Title: Torre mimetizada para cubiertas.
Inventor: RAMIREZ VERA ALFONSO
IPC: H01Q1/42
Filed: 2001-11-23
Granted: 2005-09-01
Abstract: Torre mimetizada para cubiertas para el montaje de instalaciones de telecomunicación sobre cubiertas de edificios, que comprende una estructura que se monta y fija sobre la terraza o cubierta de la edificación y que consta de un tramo superior, un tramo inferior y una cubierta externa mimetizada.